2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
15
Neoplasms
8
cyclopia sequence
7
Prostatic Neoplasms
7
Polycystic Ovary Syndrome
5
Fatigue
5
Lung Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pain
3
Obesity
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Leiomyoma
3
Vomiting
2
Urinary Bladder Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neoplasms, Plasma Cell
2
Nausea
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Insulin Resistance
2
Infertility
2
Hyperandrogenism
2
Hematologic Diseases
2
Depression
2
Burkitt Lymphoma
2
Weight Loss
1
Interventions
Metformin
3
drospirenone and ethinyl estradiol combination
2
Caloric Restriction
2
cinnulin PF
1
Yoga
1
Ultrasonography
1
Sugars
1
Robotic Surgical Procedures
1
Population Groups
1
Inositol
1
Hysterectomy
1
Hematologic Tests
1
Glucose Tolerance Test
1
Folic Acid
1
Ethinyl Estradiol
1
Doxycycline
1
Diet
1
Cyproterone acetate, ethinyl estradiol drug combination
1
Control Groups
1
Contraceptives, Oral
1
Acupuncture Therapy
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Menstruation Disturbances
×
Sugars
×
Clear all
NCT01788215
2016-01-13
MI-PCOS
University of Rochester
Phase 3
Completed
10 enrolled
14 charts